143 related articles for article (PubMed ID: 35939116)
1. Effects and mechanisms of GSG2 in esophageal cancer progression.
Geng C; Wang Q; Xing PF; Wang M; Tong SD; Zhou JY
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3409-3421. PubMed ID: 35939116
[TBL] [Abstract][Full Text] [Related]
2. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
3. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract][Full Text] [Related]
4. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
Tang Y; Dai G; Yang Y; Liu H
J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
[TBL] [Abstract][Full Text] [Related]
5. GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
Li L; Li S; Wang H; Li L; Wang P; Shen D; Dang X
Biochem Biophys Res Commun; 2022 Oct; 625():109-115. PubMed ID: 35952607
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of
Yu W; Liu W; Feng Y; Zhu C
Genet Test Mol Biomarkers; 2022 Jan; 26(1):26-36. PubMed ID: 35089075
[No Abstract] [Full Text] [Related]
8. GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer.
Huang Y; Liu Y; Zhu K; Ma X; Lu R; Zhang M
Cancer Manag Res; 2021; 13():499-508. PubMed ID: 33500663
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of GSG2 inhibits the development and progression of non-small cell lung cancer
Zhang F; Qiu B; Ji Y; Zhang H; Song P; Sun N; Zhao L; Lv F; Yin L; Gao Y; Xue Q; Gao S; He J
Cell Cycle; 2023 Jan; 22(2):153-164. PubMed ID: 35972887
[TBL] [Abstract][Full Text] [Related]
10. Germ cell-specific gene 2 accelerates cell cycle in epithelial ovarian cancer by inhibiting GSK3α-p27 cascade.
Zhu K; Ma X; Guan X; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
J Mol Histol; 2024 Jun; 55(3):241-251. PubMed ID: 38613588
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
13. Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy.
Li ZY; Li HF; Zhang YY; Zhang XL; Wang B; Liu JT
World J Gastroenterol; 2020 Apr; 26(15):1775-1791. PubMed ID: 32351293
[TBL] [Abstract][Full Text] [Related]
14. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
15. Highly expressed microRNA-124 inhibits migration and promotes apoptosis of esophageal cancer cells by degrading PDCD6.
Hu S; Zang R; Wang Y; Liang Y; Mu J; Zhang Y; Ma J
J BUON; 2019; 24(2):805-812. PubMed ID: 31128039
[TBL] [Abstract][Full Text] [Related]
16. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12).
Chen Y; Fu D; Zhao H; Cheng W; Xu F
Aging (Albany NY); 2020 May; 12(10):8858-8879. PubMed ID: 32439830
[TBL] [Abstract][Full Text] [Related]
17. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
19. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
Yin Y; Du L; Li X; Zhang X; Gao Y
J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway.
Wu S; Cai W; Shi Z; Ming X; Yang X; Zhou Y; Chen X; Yang M
Biochem Biophys Res Commun; 2022 Jul; 614():47-55. PubMed ID: 35567943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
